Navamedic Logo

Navamedic

NAVA | OL

Overview

Corporate Details

ISIN(s):
NO0010205966
LEI:
529900LKVQOR2SRUJU71
Country:
Norway
Address:
Henrik Ibsens gate 100, 0255 OSLO
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Navamedic ASA is a Nordic pharma company with a footprint in Northern Europe. We are a reliable supplier of high-quality products, delivered to hospitals and through pharmacies, meeting the specific medical needs of patients and consumers. Our product portfolio consists of prescription and OTC pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. Navamedic is present in all Nordic countries, the Baltics and Benelux and has sales of specific products even in other European countries like UK and Greece. Our headquarter is in Oslo, Norway and we are listed on the Oslo Stock Exchange (ticker: NAVA).

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-15 12:32
Regulatory News Service
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
English 5.7 KB
2025-07-15 08:25
Share Issue/Capital Change
Navamedic ASA: Ex. subscription rights today
English 523 bytes
2025-07-14 15:27
Declaration of Voting Results & Voting Rights Announcements
Navamedic ASA - Minutes of Extraordinary General Meeting - Attachment: Navamedi…
Norwegian 354.3 KB
2025-07-14 15:27
Declaration of Voting Results & Voting Rights Announcements
Navamedic ASA - Minutes of Extraordinary General Meeting
English 1.0 KB
2025-07-11 14:16
Directors' Dealings
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_JD…
Norwegian 79.4 KB
2025-07-11 14:16
Directors' Dealings
Navamedic ASA: Mandatory notice of trade
English 862 bytes
2025-07-10 10:49
Share Issue/Capital Change
Navamedic ASA: Updated key information relating to the rights issue
English 10.0 KB
2025-06-29 13:36
Share Issue/Capital Change
Navamedic ASA - Additional underwriting commitments in the Rights Issue
English 8.8 KB
2025-06-27 14:14
Regulatory News Service
Navamedic ASA: First approval of the medical device OraFID® as primary package …
English 2.8 KB
2025-06-24 08:00
Investor Presentation
Navamedic ASA - Investor presentation regarding the acquisition of the business…
English 1.1 MB
2025-06-24 08:00
Regulatory News Service
Navamedic ASA - Investor presentation regarding the acquisition of the business…
English 1.8 KB
2025-06-23 17:35
Directors' Dealings
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_Pr…
English 80.7 KB
2025-06-23 17:35
Directors' Dealings
Navamedic ASA: Mandatory notice of trade
English 876 bytes
2025-06-23 12:45
General Meeting Notice
Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in conne…
Norwegian 1.3 MB
2025-06-23 12:45
General Meeting Notice
Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in conne…
English 9.9 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
EQL Pharma AB Logo EQL Pharma AB Sweden EQL
E.S. Australia Israel Holdings LTD Israel AUIS
EuroAPI Logo EuroAPI France EAPI
Eurofins-Cerep Logo Eurofins-Cerep France ALECR
EUROPEAN GREEN TRANSITION PLC Logo EUROPEAN GREEN TRANSITION PLC United Kingdom EGT
Evolear AB Logo Evolear AB Sweden EVOL
Faes Farma S.A. Logo Faes Farma S.A. Spain FAE
Fagron N.V. Logo Fagron N.V. Belgium FAGR
Farmak Logo Farmak Ukraine FARM
Farmsintez ao Logo Farmsintez ao Russian Federation LIFE